|
Index of reports
> Cases resulting in disability (11)
> Cases with Arterial Occlusive Disease (7)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in disability where reactions include arterial occlusive disease.
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Brazil on 2007-10-30
Patient: female
Adverse reactions / side effects: Drug Ineffective, Impaired Work Ability, Ill-Defined Disorder, Palpitations, Diarrhoea, Pulmonary Oedema, Oedema, Arterial Occlusive Disease, Depression, Myocardial Infarction, Blood Glucose Increased, Haematoma
Adverse event resulted in: disablity
Suspect drug(s):
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet
Dosage: 10/5 mg (bid),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Coristina D (Acetysalicylic Acid, Cafffeine, Phenylephrine Hydrochlori
Indication: Drug USE FOR Unknown Indication
Diabinese
Dosage: 500 mg (250 mg,bid),per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Dosage: 5 mg (5 mg,qd),per oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2004-01-01
End date: 2006-01-01
Olmesartan Medoxomil
Dosage: 20 mg (20 mg,qd),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Other drugs received by patient: Insulin (Insulin) (-Injection) (Insulin)
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Novonorm
Olmetec
Administration route: Oral
Indication: Hypertension
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-05-08
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-05-04
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Impaired Work Ability, Fatigue, Malaise, Palpitations, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction
Adverse event resulted in: disablity
Suspect drug(s):
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet
Dosage: 20/10 mg (mg, bid), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet (Tablet)
Dosage: 20/10 mg (mg, bid), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Norvasc
Olmesartan Medoxomil
Dosage: 20 mg (20 mg, qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Olmetec (Olmesartan Medoxomil) (20 Milligram, Tablet) (Olmesartan Medo
Dosage: 20 mg (20 mg, qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Other drugs received by patient: Diabinese (Chlorpropamide) (Chlorpropamide); Norvasc; Insulin (Insulin) (Insulin); Diabinese; Insulin
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-05-01
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Syncope, Fatigue, Malaise, Palpitations, Arterial Occlusive Disease, Oedema, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Insulin
Indication: Diabetes Mellitus
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-04-02
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aldactone
Dosage: text:5/10 mg (milligram)
Administration route: Oral
Caduet
Administration route: Oral
Coristina D
Administration route: Oral
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Insulin
Indication: Diabetes Mellitus
Norvasc
Administration route: Oral
Olmetec
Dosage: daily dose:20mg
Administration route: Oral
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-03-20
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aldactone
Administration route: Oral
Caduet
Administration route: Oral
Coristina D
Administration route: Oral
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Insulin
Norvasc
Administration route: Oral
Olmetec
Administration route: Oral
|
